Asymmetrical changes of excitatory synaptic transmission in dopamine-denervated striatum after transient forebrain ischemia

Neuroscience

Volumn 114, Issue 2, 2002, Pages 317-326

  Pang, Z P ^a   Ling, G Y ^a   Gajendiran, M ^a   Xu, Z C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell death; Excitatory postsynaptic potential; in vivo; Intracellular recording; Lateralization

Indexed keywords

DOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL DEATH; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; ELECTROPHYSIOLOGY; EVOKED CORTICAL RESPONSE; IN VIVO STUDY; MALE; NEOSTRIATUM; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; STAINING; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN ISCHEMIA; DOPAMINE; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; FUNCTIONAL LATERALITY; MALE; MEMBRANE POTENTIALS; NEOSTRIATUM; NERVE DEGENERATION; OXIDOPAMINE; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; REACTION TIME; REPERFUSION INJURY; SYNAPTIC TRANSMISSION; TYROSINE 3-MONOOXYGENASE;

EID: 0036774851     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00309-3     Document Type: Article

References (57)

1. Breese G.R., Traylor T.D. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine. Br. J. Pharmacol. 42:1971;88-99.
2. Calabresi P., Mercuri N., Stanzione P., Stefani A., Bernardi G. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement. Neuroscience. 20:1987;757-771.
3. Calabresi P., Saulle E., Centonze D., Pisani A., Marfia G.A., Bernardi G. Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability. Brain. 125:2002;844-860.
4. Calabresi P., Centonze D., Gubellini P., Marfia G.A., Pisani A., Sancesario G., Bernardi G. Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog. Neurobiol. 61:2000;231-265.
5. Cepeda C., Buchwald N.A., Levine M.S. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc. Natl. Acad. Sci. USA. 90:1993;9576-9580.
6. Chang H.S., Sasaki T., Kassell N.F. Hippocampal unit activity after transient cerebral ischemia in rats. Stroke. 20:1989;1051-1058.
7. Cheramy A., Romo R., Godeheu G., Baruch P., Glowinski J. In vivo presynaptic control of dopamine release in the cat caudate nucleus-II. Facilitatory or inhibitory influence of L-glutamate. Neuroscience. 19:1986;1081-1090.
8. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:1990;171-182.
9. Clemens J.A., Phebus L.A. Dopamine depletion protects striatal neurons from ischemia-induced cell death. Life Sci. 42:1988;707-713.
10. Crepel V., Hammond C., Chinestra P., Diabira D., Ben-Ari Y. A selective LTP of NMDA receptor-mediated currents induced by anoxia in CA1 hippocampal neurons. J. Neurophysiol. 70:1993;2045-2055.
11. Divac I., Fonnum F., Storm-Mathisen J. High affinity uptake of glutamate in terminals of corticostriatal axons. Nature. 266:1977;377-378.
12. Drew K.L., Lyon R.A., Titeler M., Glick S.D. Asymmetry in D-2 binding in female rat striata. Brain Res. 363:1986;192-195.
13. Gajendiran M., Ling G.Y., Pang Z., Xu Z.C. Differential changes of synaptic transmission in spiny neurons of rat neostriatum following transient forebrain ischemia. Neuroscience. 105:2001;139-152.
14. Galarraga E., Hernandez-Lopez S., Reyes A., Barral J., Bargas J. Dopamine facilitates striatal EPSPs through an L-type Ca2+ conductance. NeuroReport. 8:1997;2183-2186.
15. Gao T.M., Xu Z.C. In vivo intracellular demonstration of an ischemia-induced postsynaptic potential from CA1 pyramidal neurons in rat hippocampus. Neuroscience. 75:1996;665-669.
16. Gao T.M., Howard E.M., Xu Z.C. Transient neurophysiological changes in CA3 neurons and dentate granule cells after severe forebrain ischemia in vivo. J. Neurophysiol. 80:1998;2860-2869.
17. Glick S.D., Jerussi T.P., Water D.H., Green J.P. Amphetamine-induced changes in striatal dopamine and acetylcholine levels and relationship to rotation (circling behavior) in rats. Biochem. Pharmacol. 23:1974;3223-3225.
18. Globus M.Y., Ginsberg M.D., Dietrich W.D., Busto R., Scheinberg P. Substantia nigra lesion protects against ischemic damage in the striatum. Neurosci. Lett. 80:1987;251-256.
19. Globus M.Y., Ginsberg M.D., Harik S.I., Busto R., Dietrich W.D. Role of dopamine in ischemic striatal injury: metabolic evidence. Neurology. 37:1987;1712-1719.
20. Globus M.Y., Busto R., Dietrich W.D., Martinez E., Valdes I., Ginsberg M.D. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51:1988;1455-1464.
21. Guarneri P., Guarneri R., Zarcone D., Bettinazzi G., Amato L., Piccoli F. Lateral differences in the GABAergic system of the rat striatum. Ital. J. Neurol. Sci. 6:1985;173-176.
22. Guarneri P., Guarneri R., La Bella V., Scondotto S., Scoppa F., Piccoli F. Lateral differences in GABA binding sites in rat brain. Neurochem. Res. 13:1988;209-211.
23. Hashimoto N., Matsumoto T., Mabe H., Hashitani T., Nishino H. Dopamine has inhibitory and accelerating effects on ischemia-induced neuronal cell damage in the rat striatum. Brain Res. Bull. 33:1994;281-288.
24. Hori N., Carpenter D.O. Functional and morphological changes induced by transient in vivo ischemia. Exp. Neurol. 129:1994;279-289.
25. Hsu K.S., Huang C.C., Yang C.H., Gean P.W. Presynaptic D2 dopaminergic receptors mediate inhibition of excitatory synaptic transmission in rat neostriatum. Brain Res. 690:1995;264-268.
26. Joyce J.N. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment. Exp. Neurol. 113:1991;277-290.
27. Joyce J.N. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system. Exp. Neurol. 113:1991;261-276.
28. Kiyatkin E.A., Rebec G.V. Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats. J. Neurosci. 19:1999;3594-3609.
29. Kotter R. Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum. Prog. Neurobiol. 44:1994;163-196.
30. Le Moine C., Normand E., Guitteny A.F., Fouque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. Natl. Acad. Sci. USA. 87:1990;230-234.
31. Levine M.S., Li Z., Cepeda C., Cromwell H.C., Altemus K.L. Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices. Synapse. 24:1996;65-78.
32. Lindvall, O., Bjorklund, A., 1983. Dopamine- and norepinephrine-containing neuron systems: Their anatomy in the rat brain. In: Emson, P.C. (Ed.), Chemical Neuroanaomy. Raven Press, New York, pp. 229-255.
33. Ling G.Y., Sahr R.N., Neal-Beliveau B.S., Xu Z.C. Asymmetrical up-regulation of dopamine D2 receptors in striatum after unilateral dopamine denervation. Soc. Neurosci. Abstr. 27:2001;217-292.
34. Nicola S.M., Surmeier J., Malenka R.C. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev. Neurosci. 23:2000;185-215.
35. O'Neill M.J., Hicks C.A., Ward M.A., Cardwell G.P., Reymann J.M., Allain H., Bentue-Ferrer D. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. Eur. J. Pharmacol. 352:1998;37-46.
36. Obrenovitch T.P., Sarna G.S., Matsumoto T., Symon L. Extracellular striatal dopamine and its metabolites during transient cerebral ischaemia. J. Neurochem. 54:1990;1526-1532.
37. Onn S.P., Grace A.A. Alterations in electrophysiological activity and dye coupling of striatal spiny and aspiny neurons in dopamine-denervated rat striatum recorded in vivo. Synapse. 33:1999;1-15.
38. Pang Z., Ling G.Y., Gajendiran M., Xu Z.C. Enhanced excitatory synaptic transmission in spiny neurons of rat striatum after unilateral dopamine denervation. Neurosci. Lett. 308:2001;201-205.
39. Pulsinelli W., Block G.A. Dopamine and ischemic striatal nerve cell death. Soc. Neurosci. Abstr. 13:1987;411-419.
40. Pulsinelli W.A., Brierley J.B. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke. 10:1979;267-272.
41. Pulsinelli W.A., Brierley J.B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:1982;491-498.
42. Ren Y., Li X., Xu Z.C. Asymmetrical protection of neostriatal neurons against transient forebrain ischemia by unilateral dopamine depletion. Exp. Neurol. 146:1997;250-257.
43. Schneider L.H., Murphy R.B., Coons E.E. Lateralization of striatal dopamine (D2) receptors in normal rats. Neurosci. Lett. 33:1982;281-284.
44. Sherman G.F., Galaburda A.M. Neocortical asymmetry and open-field behavior in the rat. Exp. Neurol. 86:1984;473-482.
45. Sibley D.R., Monsma F.J. Jr. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13:1992;61-69.
46. Song D.D., Haber S.N. Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting. J. Neurosci. 20:2000;5102-5114.
47. Spencer H.J. Antagonism of cortical excitation of striatal neurons by glutamic acid diethyl ester: evidence for glutamic acid as an excitatory transmitter in the rat striatum. Brain Res. 102:1976;91-101.
48. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5:1968;107-110.
49. Urban L., Neill K.H., Crain B.J., Nadler J.V., Somjen G.G. Postischemic synaptic physiology in area CA1 of the gerbil hippocampus studied in vitro. J. Neurosci. 9:1989;3966-3975.
50. Weinberger J., Nieves-Rosa J., Cohen G. Nerve terminal damage in cerebral ischemia: protective effect of alpha- methyl-para-tyrosine. Stroke. 16:1985;864-870.
51. Weiner D.M., Levey A.I., Sunahara R.K., Niznik H.B., O'Dowd B.F., Seeman P., Brann M.R. D1 and D2 dopamine receptor mRNA in rat brain. Proc. Natl. Acad. Sci. USA. 88:1991;1859-1863.
52. Wieloch T., Miyauchi Y., Lindvall O. Neuronal damage in the striatum following forebrain ischemia: lack of effect of selective lesions of mesostriatal dopamine neurons. Exp. Brain Res. 83:1990;159-163.
53. Wilson C.J., Chang H.T., Kitai S.T. Disfacilitation and long-lasting inhibition of neostriatal neurons in the rat. Exp. Brain Res. 51:1983;227-235.
54. Xu Z.C. Neurophysiological changes of spiny neurons in rat neostriatum after transient forebrain ischemia: an in vivo intracellular recording and staining study. Neuroscience. 67:1995;823-836.
55. Xu Z.C., Pulsinelli W.A. Responses of CA1 pyramidal neurons in rat hippocampus to transient forebrain ischemia: an in vivo intracellular recording study. Neurosci. Lett. 171:1994;187-191.
56. Xu Z.C., Pulsinelli W.A. Electrophysiological changes of CA1 pyramidal neurons following transient forebrain ischemia: an in vivo intracellular recording and staining study. J. Neurophysiol. 76:1996;1689-1697.
57. Xu Z.C., Chwang W., Li X., Chen X., He P. Gender difference in dopamine concentration and postischemic neuronal damage in neostriatum after unilateral dopamine depletion. Exp. Neurol. 158:1999;182-191.